FDA warning letters
FDA warning and untitled letters to telehealth companies, compounders and peptide sellers, with responses and close-outs.
CSV · 27 columns · Updated when FDA posts new letters; we check FDA’s postings at least weekly.
Data
Trackers and data
Sourced, downloadable trackers of FDA warning letters, federal regulatory actions, expiring telehealth policies and the regulatory status of peptides, updated as agencies act.
The trackers
Structured records you can cite, filter and download.
Every tracker is a sourced table with a methodology note, a CSV download and citation text. Each regulatory action and peptide has its own permanent page; each policy has a permanent entry on the deadlines tracker.
Records appear here as soon as they are verified.
-
-
Telehealth regulatory actions
Approvals, rules, guidance, recalls and enforcement from FDA, DEA, CMS, HHS and FTC.
CSV · 27 columns · Updated as agencies publish; Federal Register and FDA postings are checked each business day.
-
Telehealth policy deadlines
Countdowns to expiring telehealth flexibilities, with legal authority and timelines.
CSV · 16 columns · Checked at least weekly, and on the day any extension or rule is published.
-
Peptide regulatory status
503A status, FDA approval, PCAC votes and WADA status for peptides sold online.
152 peptides tracked
CSV · 19 columns · Checked at least weekly and whenever FDA updates its 503A lists or holds a PCAC meeting.
Reference databases
-
Drugs
Approval, shortage and compounding status of the drugs we cover.
-
Companies
Telehealth companies, drugmakers, pharmacies and compounders, with the regulatory actions naming them.
-
Agencies
The federal agencies whose rules and enforcement we track.
-
Organizations
Trade and professional associations.
-
Glossary
Plain-English definitions of the regulatory terms behind every Status Label.